Published in Vaccine on July 31, 2012
Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins. BMC Infect Dis (2013) 0.77
Physicochemical property consensus sequences for functional analysis, design of multivalent antigens and targeted antivirals. BMC Bioinformatics (2012) 0.77
Sequence specificity for uridylylation of the viral peptide linked to the genome (VPg) of enteroviruses. Virology (2015) 0.76
Allosteric inhibitors of Coxsackie virus A24 RNA polymerase. Bioorg Med Chem (2015) 0.75
MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res (2004) 168.89
MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics (2004) 50.89
Profile analysis: detection of distantly related proteins. Proc Natl Acad Sci U S A (1987) 29.26
Multiple sequence alignment using ClustalW and ClustalX. Curr Protoc Bioinformatics (2002) 9.86
Research on dengue during World War II. Am J Trop Med Hyg (1952) 8.76
Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol (2005) 3.58
Microevolution and virulence of dengue viruses. Adv Virus Res (2003) 3.41
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol (2008) 3.27
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol (2006) 3.23
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol (2007) 2.89
Progress towards a dengue vaccine. Lancet Infect Dis (2009) 2.45
Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. J Virol (2008) 1.98
An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol (2004) 1.81
From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil. PLoS Negl Trop Dis (2011) 1.70
Dengue virus evolution and virulence models. Clin Infect Dis (2007) 1.64
Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol (2003) 1.61
A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology (2006) 1.54
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Vaccine (2009) 1.48
Highly sensitive detection of dengue virus nucleic acid in samples from clinically ill patients. J Clin Microbiol (2009) 1.43
Review of dengue virus and the development of a vaccine. Biotechnol Adv (2010) 1.35
The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. Microbes Infect (2006) 1.33
Flavivirus-induced antibody cross-reactivity. J Gen Virol (2011) 1.28
Profile analysis. Methods Mol Biol (1994) 1.28
Solution structure of the envelope protein domain III of dengue-4 virus. Virology (2007) 1.27
Dengue deaths in Puerto Rico: lessons learned from the 2007 epidemic. PLoS Negl Trop Dis (2012) 1.23
Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III. Virology (2008) 1.13
Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate. J Infect Dis (2011) 1.11
Domain III of the envelope protein as a dengue vaccine target. Expert Rev Vaccines (2010) 1.10
Homology modeling and characterization of IgE binding epitopes of mountain cedar allergen Jun a 3. Biophys J (2000) 1.09
A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus. Virology (2006) 1.08
Molego-based definition of the architecture and specificity of metal-binding sites. Proteins (2005) 1.05
A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity. Microbes Infect (2008) 1.05
Comprehensive 3D-modeling of allergenic proteins and amino acid composition of potential conformational IgE epitopes. Mol Immunol (2008) 1.05
Integrated dataset of screening hits against multiple neglected disease pathogens. PLoS Negl Trop Dis (2011) 1.03
Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice. Vaccine (2008) 1.03
Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates. Antiviral Res (2008) 1.00
Alphavirus antiviral drug development: scientific gap analysis and prospective research areas. Biosecur Bioterror (2009) 0.98
Using property based sequence motifs and 3D modeling to determine structure and functional regions of proteins. Curr Med Chem (2004) 0.98
Homology modeling and simulations of nuclease structures. Methods Mol Biol (2001) 0.98
CTree: comparison of clusters between phylogenetic trees made easy. Bioinformatics (2007) 0.98
Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice. Virus Res (2006) 0.94
Exploiting antigenic diversity for vaccine design: the chlamydia ArtJ paradigm. J Biol Chem (2010) 0.94
Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III. Virology (2010) 0.94
Evolutionary trace for prediction and redesign of protein functional sites. Methods Mol Biol (2012) 0.94
Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes. Vaccine (2009) 0.92
PHOG-BLAST--a new generation tool for fast similarity search of protein families. BMC Evol Biol (2006) 0.91
Optimal classification of protein sequences and selection of representative sets from multiple alignments: application to homologous families and lessons for structural genomics. Protein Eng (2001) 0.89
Total sequence decomposition distinguishes functional modules, "molegos" in apurinic/apyrimidinic endonucleases. BMC Bioinformatics (2002) 0.89
Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate. Vaccine (2009) 0.88
PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype. J Mol Biol (2009) 0.88
Consensus sequences improve PSI-BLAST through mimicking profile-profile alignments. Nucleic Acids Res (2007) 0.84
Sequence signatures in envelope protein may determine whether flaviviruses produce hemorrhagic or encephalitic syndromes. Virus Genes (2009) 0.82
Antibodies induced by dengue virus type 1 and 2 envelope domain III recombinant proteins in monkeys neutralize strains with different genotypes. Clin Vaccine Immunol (2009) 0.82
Evolution of attenuating mutations in dengue-2 strain S16803 PDK50 vaccine and comparison of growth kinetics with parent virus. Virus Genes (2011) 0.81
NMR assignments of the sylvatic dengue 1 virus envelope protein domain III. Biomol NMR Assign (2008) 0.81
Systematic analysis of host immunological pressure on the envelope gene of human immunodeficiency virus type 1 by an immunobioinformatics approach. Curr HIV Res (2008) 0.80
Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles. J Virol Methods (2010) 0.80
PCR detection of nearly any dengue virus strain using a highly sensitive primer 'cocktail'. FEBS J (2011) 0.80
Flavitrack analysis of the structure and function of West Nile non-structural proteins. Int J Bioinform Res Appl (2010) 0.80
Virus role during intraepidemic increase in dengue disease severity. Vector Borne Zoonotic Dis (2011) 0.79
Balance of infection-enhancing and neutralizing antibodies induced by a dengue tetravalent DNA vaccine in a mouse model. Microbes Infect (2011) 0.78
Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice. Biotechnol Appl Biochem (2009) 0.77
Persistent infection with West Nile virus years after initial infection. J Infect Dis (2010) 3.33
Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label study. Arch Dermatol (2011) 2.13
SDAP: database and computational tools for allergenic proteins. Nucleic Acids Res (2003) 1.61
A "moving metal mechanism" for substrate cleavage by the DNA repair endonuclease APE-1. Proteins (2007) 1.16
Identifying property based sequence motifs in protein families and superfamilies: application to DNase-1 related endonucleases. Bioinformatics (2003) 1.15
InterProSurf: a web server for predicting interacting sites on protein surfaces. Bioinformatics (2007) 1.14
Data mining of sequences and 3D structures of allergenic proteins. Bioinformatics (2002) 1.10
Membrane-protein interactions contribute to efficient 27-hydroxylation of cholesterol by mitochondrial cytochrome P450 27A1. J Biol Chem (2002) 1.08
Comprehensive 3D-modeling of allergenic proteins and amino acid composition of potential conformational IgE epitopes. Mol Immunol (2008) 1.05
Novel inhibitors of anthrax edema factor. Bioorg Med Chem (2008) 1.03
Major linear IgE epitopes of mountain cedar pollen allergen Jun a 1 map to the pectate lyase catalytic site. Mol Immunol (2003) 1.02
Determining functionally important amino acid residues of the E1 protein of Venezuelan equine encephalitis virus. J Mol Model (2006) 1.00
The property distance index PD predicts peptides that cross-react with IgE antibodies. Mol Immunol (2008) 0.99
Characteristic motifs for families of allergenic proteins. Mol Immunol (2008) 0.98
Using property based sequence motifs and 3D modeling to determine structure and functional regions of proteins. Curr Med Chem (2004) 0.98
Effects of backbone contacts 3' to the abasic site on the cleavage and the product binding by human apurinic/apyrimidinic endonuclease (APE1). Biochemistry (2004) 0.97
Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III. Virology (2010) 0.94
Structural basis for epitope sharing between group 1 allergens of cedar pollen. Mol Immunol (2005) 0.91
Detecting potential IgE-reactive sites on food proteins using a sequence and structure database, SDAP-food. J Agric Food Chem (2003) 0.90
Structural and functional analysis of Aplysia attractins, a family of water-borne protein pheromones with interspecific attractiveness. Proc Natl Acad Sci U S A (2004) 0.90
PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype. J Mol Biol (2009) 0.88
Flavitrack: an annotated database of flavivirus sequences. Bioinformatics (2007) 0.87
Accounting for ligand-bound metal ions in docking small molecules on adenylyl cyclase toxins. Proteins (2007) 0.85
Structural analysis of linear and conformational epitopes of allergens. Regul Toxicol Pharmacol (2008) 0.85
Testing the efficacy and toxicity of adenylyl cyclase inhibitors against enteric pathogens using in vitro and in vivo models of infection. Infect Immun (2010) 0.85
Computational selection of inhibitors of Abeta aggregation and neuronal toxicity. Bioorg Med Chem (2009) 0.85
NMR solution structure of attractin, a water-borne protein pheromone from the mollusk Aplysia californica. Biochemistry (2003) 0.84
Aplysia temptin - the 'glue' in the water-borne attractin pheromone complex. FEBS J (2007) 0.84
Ara h 1 structure is retained after roasting and is important for enhanced binding to IgE. Mol Nutr Food Res (2012) 0.83
Flavitrack analysis of the structure and function of West Nile non-structural proteins. Int J Bioinform Res Appl (2010) 0.80
MD simulation and experimental evidence for Mg²+ binding at the B site in human AP endonuclease 1. Bioinformation (2011) 0.80
Newly identified water-borne protein pheromones interact with attractin to stimulate mate attraction in Aplysia. Peptides (2005) 0.80
A general synthetic method toward uridylylated picornavirus VPg proteins. J Pept Sci (2013) 0.79
Structure-based redesign of an edema toxin inhibitor. Bioorg Med Chem (2011) 0.79
Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides. Peptides (2010) 0.78
Molluscan attractins, a family of water-borne protein pheromones with interspecific attractiveness. Peptides (2005) 0.77
Physicochemical property consensus sequences for functional analysis, design of multivalent antigens and targeted antivirals. BMC Bioinformatics (2012) 0.77
Assessment of 3D models for allergen research. Proteins (2013) 0.76
AllerML: markup language for allergens. Regul Toxicol Pharmacol (2011) 0.75
A cool way to make proteins. Nat Biotechnol (2004) 0.75
D-graph clusters flaviviruses and β-coronaviruses according to their hosts, disease type and human cell receptors. bioRxiv (2020) 0.75
Recombinant production and structural studies of the Aplysia water-borne protein pheromone enticin indicates it has a novel disulfide stabilized fold. Peptides (2006) 0.75